| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 30 | 2024 | 271 | 8.890 |
Why?
|
| Vascular Surgical Procedures | 23 | 2024 | 565 | 4.460 |
Why?
|
| Lower Extremity | 19 | 2023 | 179 | 3.910 |
Why?
|
| Diabetic Foot | 12 | 2022 | 155 | 3.890 |
Why?
|
| Ischemia | 15 | 2024 | 343 | 3.400 |
Why?
|
| Intermittent Claudication | 7 | 2020 | 55 | 3.160 |
Why?
|
| Liver Transplantation | 30 | 2008 | 1015 | 2.890 |
Why?
|
| Osteomyelitis | 5 | 2019 | 204 | 2.400 |
Why?
|
| Endovascular Procedures | 19 | 2024 | 729 | 2.300 |
Why?
|
| Gangrene | 5 | 2023 | 26 | 2.050 |
Why?
|
| Health Care Costs | 5 | 2017 | 364 | 1.880 |
Why?
|
| Islets of Langerhans Transplantation | 10 | 2006 | 31 | 1.870 |
Why?
|
| Leg | 6 | 2022 | 155 | 1.870 |
Why?
|
| Limb Salvage | 13 | 2024 | 120 | 1.800 |
Why?
|
| Walking | 5 | 2019 | 207 | 1.750 |
Why?
|
| Aortic Aneurysm, Abdominal | 9 | 2022 | 443 | 1.710 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2021 | 825 | 1.660 |
Why?
|
| Foot | 4 | 2023 | 63 | 1.560 |
Why?
|
| Surgical Wound Infection | 7 | 2020 | 261 | 1.460 |
Why?
|
| Aortic Rupture | 3 | 2022 | 118 | 1.370 |
Why?
|
| Blood Vessel Prosthesis Implantation | 14 | 2020 | 796 | 1.360 |
Why?
|
| Tissue and Organ Procurement | 10 | 2007 | 218 | 1.340 |
Why?
|
| Models, Economic | 5 | 2017 | 51 | 1.310 |
Why?
|
| Foot Ulcer | 3 | 2019 | 19 | 1.270 |
Why?
|
| Treatment Outcome | 55 | 2024 | 12115 | 1.240 |
Why?
|
| Aged | 53 | 2024 | 19093 | 1.220 |
Why?
|
| Healthcare Disparities | 4 | 2024 | 417 | 1.210 |
Why?
|
| Carotid Stenosis | 6 | 2021 | 133 | 1.170 |
Why?
|
| Middle Aged | 62 | 2024 | 25992 | 1.110 |
Why?
|
| Exercise Tolerance | 2 | 2018 | 75 | 1.090 |
Why?
|
| Health Behavior | 3 | 2018 | 381 | 1.060 |
Why?
|
| Humans | 136 | 2024 | 123103 | 1.060 |
Why?
|
| Risk Factors | 35 | 2024 | 10018 | 1.030 |
Why?
|
| Foot Diseases | 2 | 2017 | 24 | 1.030 |
Why?
|
| Stents | 10 | 2020 | 877 | 0.960 |
Why?
|
| Graft Survival | 13 | 2012 | 525 | 0.940 |
Why?
|
| Male | 82 | 2024 | 60129 | 0.930 |
Why?
|
| Retrospective Studies | 48 | 2024 | 16044 | 0.910 |
Why?
|
| Texas | 16 | 2022 | 3563 | 0.890 |
Why?
|
| Exercise | 3 | 2019 | 813 | 0.880 |
Why?
|
| Time Factors | 36 | 2024 | 6219 | 0.880 |
Why?
|
| Medicaid | 2 | 2022 | 245 | 0.860 |
Why?
|
| Bacteria | 2 | 2019 | 482 | 0.830 |
Why?
|
| Postoperative Complications | 16 | 2020 | 3011 | 0.820 |
Why?
|
| Wound Healing | 9 | 2020 | 451 | 0.820 |
Why?
|
| Cause of Death | 4 | 2018 | 462 | 0.820 |
Why?
|
| Aged, 80 and over | 22 | 2021 | 6374 | 0.760 |
Why?
|
| Female | 74 | 2024 | 65514 | 0.760 |
Why?
|
| Vascular Diseases | 2 | 2021 | 163 | 0.760 |
Why?
|
| Cost-Benefit Analysis | 8 | 2017 | 500 | 0.750 |
Why?
|
| Exercise Therapy | 2 | 2019 | 149 | 0.720 |
Why?
|
| Anemia | 2 | 2022 | 340 | 0.710 |
Why?
|
| Markov Chains | 6 | 2017 | 83 | 0.680 |
Why?
|
| Patient Care Bundles | 1 | 2020 | 23 | 0.680 |
Why?
|
| Tibia | 1 | 2020 | 70 | 0.680 |
Why?
|
| Arterial Occlusive Diseases | 6 | 2019 | 127 | 0.680 |
Why?
|
| Vascular Grafting | 5 | 2019 | 44 | 0.680 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 113 | 0.680 |
Why?
|
| Cost Savings | 2 | 2017 | 69 | 0.670 |
Why?
|
| Delay Discounting | 1 | 2019 | 7 | 0.670 |
Why?
|
| Economics, Behavioral | 1 | 2019 | 6 | 0.670 |
Why?
|
| Vascular Patency | 10 | 2020 | 203 | 0.670 |
Why?
|
| Treatment Failure | 3 | 2019 | 334 | 0.660 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2024 | 94 | 0.640 |
Why?
|
| Tissue Donors | 6 | 2007 | 496 | 0.640 |
Why?
|
| Patient Compliance | 2 | 2019 | 464 | 0.640 |
Why?
|
| Liver Failure | 5 | 2007 | 89 | 0.640 |
Why?
|
| Veterans Health | 2 | 2019 | 173 | 0.630 |
Why?
|
| Health Status Disparities | 1 | 2021 | 220 | 0.630 |
Why?
|
| Waiting Lists | 5 | 2007 | 225 | 0.610 |
Why?
|
| Fenofibrate | 1 | 2018 | 58 | 0.610 |
Why?
|
| Health Resources | 1 | 2019 | 115 | 0.600 |
Why?
|
| Recovery of Function | 3 | 2015 | 437 | 0.590 |
Why?
|
| Soft Tissue Infections | 1 | 2018 | 83 | 0.580 |
Why?
|
| Veins | 1 | 2018 | 106 | 0.570 |
Why?
|
| Severity of Illness Index | 13 | 2024 | 2847 | 0.570 |
Why?
|
| Lymphoproliferative Disorders | 5 | 2006 | 224 | 0.570 |
Why?
|
| Fear | 2 | 2017 | 201 | 0.560 |
Why?
|
| Risk Assessment | 13 | 2024 | 3325 | 0.560 |
Why?
|
| Surgeons | 1 | 2021 | 247 | 0.560 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 1236 | 0.560 |
Why?
|
| Medical Errors | 3 | 2019 | 155 | 0.560 |
Why?
|
| Smoking Cessation | 1 | 2018 | 196 | 0.550 |
Why?
|
| Bone and Bones | 1 | 2019 | 262 | 0.550 |
Why?
|
| Avoidance Learning | 1 | 2017 | 56 | 0.550 |
Why?
|
| Reoperation | 9 | 2020 | 818 | 0.540 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2016 | 20 | 0.540 |
Why?
|
| United States | 20 | 2024 | 10651 | 0.530 |
Why?
|
| Infection Control | 1 | 2018 | 159 | 0.530 |
Why?
|
| Liver Failure, Acute | 3 | 2006 | 87 | 0.530 |
Why?
|
| Specialties, Surgical | 2 | 2015 | 79 | 0.490 |
Why?
|
| Staphylococcal Infections | 2 | 2019 | 552 | 0.490 |
Why?
|
| Saphenous Vein | 2 | 2013 | 53 | 0.490 |
Why?
|
| Hospitalization | 2 | 2021 | 1739 | 0.490 |
Why?
|
| Amputees | 1 | 2015 | 9 | 0.480 |
Why?
|
| Environment | 1 | 2016 | 142 | 0.480 |
Why?
|
| Mobility Limitation | 1 | 2015 | 23 | 0.480 |
Why?
|
| Compartment Syndromes | 1 | 2015 | 31 | 0.480 |
Why?
|
| Patient Selection | 5 | 2014 | 683 | 0.480 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 848 | 0.480 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2019 | 533 | 0.480 |
Why?
|
| Self Concept | 1 | 2016 | 157 | 0.470 |
Why?
|
| Multivariate Analysis | 13 | 2017 | 1413 | 0.470 |
Why?
|
| Hospital Costs | 2 | 2014 | 177 | 0.470 |
Why?
|
| Renal Dialysis | 4 | 2024 | 842 | 0.470 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 593 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2006 | 796 | 0.470 |
Why?
|
| Social Behavior | 1 | 2016 | 207 | 0.460 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2016 | 220 | 0.460 |
Why?
|
| Follow-Up Studies | 13 | 2017 | 5039 | 0.460 |
Why?
|
| Pain | 1 | 2017 | 469 | 0.450 |
Why?
|
| Kidney Failure, Chronic | 4 | 2024 | 864 | 0.440 |
Why?
|
| Databases as Topic | 2 | 2011 | 71 | 0.440 |
Why?
|
| Wound Closure Techniques | 1 | 2013 | 23 | 0.440 |
Why?
|
| Proportional Hazards Models | 8 | 2018 | 1305 | 0.440 |
Why?
|
| Survival Analysis | 8 | 2017 | 1473 | 0.430 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 89 | 0.420 |
Why?
|
| Survival Rate | 9 | 2019 | 1999 | 0.420 |
Why?
|
| Health Status | 3 | 2016 | 374 | 0.420 |
Why?
|
| Chi-Square Distribution | 6 | 2018 | 586 | 0.410 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2018 | 1004 | 0.410 |
Why?
|
| Acute Kidney Injury | 2 | 2017 | 614 | 0.410 |
Why?
|
| Health Care Rationing | 3 | 2007 | 58 | 0.400 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 1001 | 0.400 |
Why?
|
| Time-to-Treatment | 1 | 2013 | 186 | 0.390 |
Why?
|
| Adult | 27 | 2024 | 29009 | 0.390 |
Why?
|
| Popliteal Artery | 1 | 2012 | 53 | 0.390 |
Why?
|
| Odds Ratio | 9 | 2018 | 1242 | 0.380 |
Why?
|
| Cohort Studies | 9 | 2020 | 4699 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 2393 | 0.370 |
Why?
|
| Biliary Atresia | 4 | 2006 | 186 | 0.360 |
Why?
|
| Iliac Artery | 3 | 2019 | 92 | 0.350 |
Why?
|
| Femoral Artery | 3 | 2020 | 190 | 0.350 |
Why?
|
| Hospitals | 3 | 2022 | 393 | 0.350 |
Why?
|
| Palliative Care | 1 | 2014 | 428 | 0.350 |
Why?
|
| Societies, Medical | 3 | 2021 | 676 | 0.350 |
Why?
|
| Prevalence | 4 | 2017 | 2395 | 0.340 |
Why?
|
| Aneurysm, False | 2 | 2008 | 102 | 0.340 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2015 | 664 | 0.330 |
Why?
|
| Interprofessional Relations | 1 | 2011 | 144 | 0.330 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2019 | 95 | 0.330 |
Why?
|
| Cation Transport Proteins | 2 | 2007 | 96 | 0.320 |
Why?
|
| Demography | 2 | 2007 | 239 | 0.320 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 206 | 0.320 |
Why?
|
| Blood Transfusion | 3 | 2022 | 304 | 0.310 |
Why?
|
| Immunosuppressive Agents | 5 | 2006 | 642 | 0.310 |
Why?
|
| Leadership | 1 | 2011 | 230 | 0.310 |
Why?
|
| General Surgery | 2 | 2015 | 203 | 0.310 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 214 | 0.300 |
Why?
|
| Veterans | 3 | 2019 | 1733 | 0.300 |
Why?
|
| Advisory Committees | 3 | 2017 | 148 | 0.290 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2016 | 51 | 0.290 |
Why?
|
| Incidence | 7 | 2019 | 3039 | 0.290 |
Why?
|
| Thoracic Neoplasms | 1 | 2007 | 36 | 0.290 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2007 | 20 | 0.280 |
Why?
|
| Endarterectomy, Carotid | 3 | 2015 | 92 | 0.280 |
Why?
|
| Angioplasty, Balloon | 3 | 2016 | 161 | 0.280 |
Why?
|
| Regional Blood Flow | 2 | 2020 | 213 | 0.280 |
Why?
|
| Islets of Langerhans | 2 | 2005 | 173 | 0.280 |
Why?
|
| Graft Rejection | 5 | 2012 | 582 | 0.280 |
Why?
|
| Liver Diseases | 3 | 2007 | 363 | 0.270 |
Why?
|
| Propionates | 1 | 2006 | 30 | 0.270 |
Why?
|
| Policy Making | 1 | 2007 | 59 | 0.270 |
Why?
|
| Predictive Value of Tests | 8 | 2024 | 2112 | 0.270 |
Why?
|
| Length of Stay | 6 | 2018 | 1288 | 0.270 |
Why?
|
| Patient Care Team | 1 | 2011 | 548 | 0.270 |
Why?
|
| American Heart Association | 3 | 2017 | 295 | 0.260 |
Why?
|
| Sex Factors | 2 | 2021 | 1261 | 0.260 |
Why?
|
| Ankle Brachial Index | 2 | 2016 | 38 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2015 | 2055 | 0.260 |
Why?
|
| Prognosis | 7 | 2018 | 4512 | 0.250 |
Why?
|
| Heart Failure | 1 | 2018 | 2128 | 0.250 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2006 | 98 | 0.250 |
Why?
|
| Hepatitis C | 2 | 2006 | 364 | 0.250 |
Why?
|
| Registries | 5 | 2018 | 1394 | 0.250 |
Why?
|
| Quality of Life | 4 | 2016 | 1923 | 0.250 |
Why?
|
| Parenteral Nutrition | 1 | 2006 | 183 | 0.250 |
Why?
|
| Aneurysm | 2 | 2017 | 88 | 0.240 |
Why?
|
| Arachnoid | 1 | 2005 | 8 | 0.240 |
Why?
|
| Subarachnoid Space | 1 | 2005 | 24 | 0.240 |
Why?
|
| Aortic Aneurysm | 3 | 2014 | 224 | 0.240 |
Why?
|
| Attitude | 1 | 2005 | 118 | 0.240 |
Why?
|
| Iatrogenic Disease | 2 | 2013 | 132 | 0.240 |
Why?
|
| Logistic Models | 8 | 2018 | 1797 | 0.240 |
Why?
|
| West Nile Fever | 1 | 2006 | 139 | 0.240 |
Why?
|
| Disease Management | 3 | 2017 | 514 | 0.240 |
Why?
|
| Forearm | 1 | 2024 | 44 | 0.230 |
Why?
|
| Cerebrospinal Fluid | 1 | 2005 | 93 | 0.230 |
Why?
|
| Interleukin-1 | 1 | 2005 | 143 | 0.230 |
Why?
|
| Hepacivirus | 1 | 2006 | 241 | 0.230 |
Why?
|
| Alanine Transaminase | 1 | 2005 | 150 | 0.230 |
Why?
|
| Growth Disorders | 1 | 2006 | 207 | 0.230 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 186 | 0.230 |
Why?
|
| Hepatic Veins | 1 | 2004 | 22 | 0.230 |
Why?
|
| Ileal Diseases | 1 | 2004 | 21 | 0.230 |
Why?
|
| Carotid Artery, Common | 2 | 2015 | 73 | 0.230 |
Why?
|
| Antimetabolites | 1 | 2004 | 33 | 0.220 |
Why?
|
| Angioplasty | 3 | 2013 | 85 | 0.220 |
Why?
|
| Calcineurin Inhibitors | 1 | 2004 | 28 | 0.220 |
Why?
|
| Chronic Disease | 4 | 2020 | 1162 | 0.220 |
Why?
|
| Ganciclovir | 1 | 2004 | 102 | 0.220 |
Why?
|
| Age Factors | 4 | 2018 | 2799 | 0.220 |
Why?
|
| Intussusception | 1 | 2004 | 46 | 0.220 |
Why?
|
| Heptanoic Acids | 1 | 2003 | 77 | 0.220 |
Why?
|
| Career Choice | 1 | 2004 | 144 | 0.220 |
Why?
|
| Massachusetts | 2 | 2015 | 124 | 0.220 |
Why?
|
| Cytomegalovirus | 2 | 2005 | 269 | 0.210 |
Why?
|
| Groin | 2 | 2013 | 15 | 0.210 |
Why?
|
| Epstein-Barr Virus Infections | 4 | 2006 | 289 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 1258 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 220 | 0.210 |
Why?
|
| Cost of Illness | 2 | 2017 | 242 | 0.210 |
Why?
|
| Diabetic Neuropathies | 3 | 2017 | 58 | 0.210 |
Why?
|
| Critical Illness | 4 | 2018 | 591 | 0.200 |
Why?
|
| Prosthesis-Related Infections | 2 | 2016 | 176 | 0.200 |
Why?
|
| Health Surveys | 2 | 2018 | 241 | 0.200 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 578 | 0.200 |
Why?
|
| Computer Simulation | 2 | 2016 | 630 | 0.200 |
Why?
|
| Pyrroles | 1 | 2003 | 178 | 0.200 |
Why?
|
| Sirolimus | 1 | 2003 | 220 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 360 | 0.200 |
Why?
|
| Surveys and Questionnaires | 4 | 2017 | 3664 | 0.200 |
Why?
|
| Prospective Studies | 10 | 2024 | 6028 | 0.190 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2012 | 105 | 0.190 |
Why?
|
| Cytomegalovirus Infections | 1 | 2004 | 217 | 0.190 |
Why?
|
| Comorbidity | 5 | 2014 | 1497 | 0.190 |
Why?
|
| Lung Transplantation | 1 | 2005 | 316 | 0.190 |
Why?
|
| Transplantation, Homologous | 4 | 2007 | 659 | 0.190 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 317 | 0.190 |
Why?
|
| Adolescent | 13 | 2019 | 19094 | 0.190 |
Why?
|
| Cardiology | 2 | 2016 | 473 | 0.190 |
Why?
|
| Culturally Competent Care | 1 | 2021 | 45 | 0.180 |
Why?
|
| Child, Preschool | 12 | 2008 | 13888 | 0.180 |
Why?
|
| Graft vs Host Disease | 1 | 2005 | 543 | 0.180 |
Why?
|
| Liver | 5 | 2008 | 1734 | 0.180 |
Why?
|
| Recurrence | 4 | 2019 | 1419 | 0.180 |
Why?
|
| Glomerular Filtration Rate | 2 | 2014 | 481 | 0.170 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 2840 | 0.170 |
Why?
|
| Heart Transplantation | 1 | 2007 | 854 | 0.170 |
Why?
|
| Spatial Analysis | 1 | 2019 | 21 | 0.170 |
Why?
|
| Algorithms | 2 | 2006 | 1598 | 0.170 |
Why?
|
| Transportation | 1 | 2019 | 26 | 0.170 |
Why?
|
| Hospitals, Low-Volume | 1 | 2019 | 30 | 0.170 |
Why?
|
| Students, Medical | 1 | 2004 | 361 | 0.170 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 50 | 0.170 |
Why?
|
| Geography | 1 | 2019 | 110 | 0.170 |
Why?
|
| Hospitals, High-Volume | 1 | 2019 | 35 | 0.170 |
Why?
|
| History, 20th Century | 2 | 2015 | 381 | 0.170 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 34 | 0.170 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 180 | 0.170 |
Why?
|
| Cadaver | 4 | 2007 | 129 | 0.160 |
Why?
|
| Medicare | 1 | 2022 | 424 | 0.160 |
Why?
|
| Operating Rooms | 1 | 2019 | 71 | 0.160 |
Why?
|
| Disease Progression | 4 | 2016 | 2028 | 0.160 |
Why?
|
| Operative Time | 3 | 2019 | 160 | 0.160 |
Why?
|
| Aortography | 3 | 2015 | 200 | 0.160 |
Why?
|
| Enterococcus | 1 | 2019 | 32 | 0.160 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 30 | 0.160 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 859 | 0.150 |
Why?
|
| Arteries | 1 | 2019 | 221 | 0.150 |
Why?
|
| Diabetic Angiopathies | 2 | 2017 | 59 | 0.150 |
Why?
|
| Apoptosis | 1 | 2005 | 1782 | 0.150 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 155 | 0.150 |
Why?
|
| Wound Infection | 1 | 2018 | 51 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 449 | 0.150 |
Why?
|
| Propensity Score | 3 | 2020 | 211 | 0.150 |
Why?
|
| Patient Readmission | 3 | 2020 | 368 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 235 | 0.140 |
Why?
|
| Reperfusion Injury | 2 | 2008 | 101 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 1 | 2019 | 181 | 0.140 |
Why?
|
| Serum Albumin | 1 | 2017 | 107 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2015 | 50 | 0.140 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 5 | 0.140 |
Why?
|
| Angiography | 2 | 2015 | 215 | 0.140 |
Why?
|
| Prosthesis Design | 5 | 2020 | 672 | 0.130 |
Why?
|
| Biopsy | 2 | 2019 | 1236 | 0.130 |
Why?
|
| Radiography | 5 | 2013 | 822 | 0.130 |
Why?
|
| Databases, Factual | 3 | 2006 | 1172 | 0.130 |
Why?
|
| Child | 12 | 2008 | 24228 | 0.130 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 164 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2016 | 715 | 0.130 |
Why?
|
| Low Back Pain | 1 | 2016 | 34 | 0.130 |
Why?
|
| Hemoglobins | 2 | 2017 | 301 | 0.130 |
Why?
|
| Hepatocytes | 3 | 2007 | 225 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2017 | 1389 | 0.130 |
Why?
|
| Learning Curve | 2 | 2012 | 53 | 0.130 |
Why?
|
| Equipment Design | 2 | 2015 | 604 | 0.130 |
Why?
|
| Self Report | 1 | 2018 | 515 | 0.130 |
Why?
|
| Immunity, Cellular | 2 | 2006 | 201 | 0.130 |
Why?
|
| Pancreas Transplantation | 2 | 2006 | 35 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2019 | 455 | 0.120 |
Why?
|
| Artificial Limbs | 1 | 2015 | 7 | 0.120 |
Why?
|
| Fasciotomy | 1 | 2015 | 27 | 0.120 |
Why?
|
| Age Distribution | 2 | 2006 | 406 | 0.120 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 120 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2015 | 69 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 372 | 0.120 |
Why?
|
| Infant | 9 | 2007 | 12357 | 0.120 |
Why?
|
| Acute Disease | 2 | 2015 | 1093 | 0.120 |
Why?
|
| Silver Compounds | 1 | 2014 | 6 | 0.120 |
Why?
|
| Polyethylenes | 1 | 2014 | 8 | 0.120 |
Why?
|
| Alginates | 1 | 2014 | 18 | 0.120 |
Why?
|
| Patient Safety | 1 | 2019 | 394 | 0.120 |
Why?
|
| History, 19th Century | 1 | 2015 | 115 | 0.120 |
Why?
|
| Vena Cava Filters | 1 | 2014 | 21 | 0.120 |
Why?
|
| Polyesters | 1 | 2014 | 40 | 0.120 |
Why?
|
| Osteoarthritis | 1 | 2016 | 86 | 0.120 |
Why?
|
| Prosthesis Fitting | 1 | 2014 | 7 | 0.120 |
Why?
|
| Decompression, Surgical | 1 | 2015 | 92 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 3 | 2006 | 663 | 0.120 |
Why?
|
| Heart Diseases | 2 | 2017 | 482 | 0.120 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 35 | 0.110 |
Why?
|
| Chemistry, Clinical | 1 | 2014 | 13 | 0.110 |
Why?
|
| Bandages | 1 | 2014 | 55 | 0.110 |
Why?
|
| Vancomycin | 2 | 2013 | 218 | 0.110 |
Why?
|
| Foreign-Body Migration | 1 | 2014 | 74 | 0.110 |
Why?
|
| Renal Artery Obstruction | 1 | 2014 | 41 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 70 | 0.110 |
Why?
|
| Carotid Artery Injuries | 1 | 2013 | 39 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2019 | 626 | 0.110 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 35 | 0.110 |
Why?
|
| Skin Transplantation | 1 | 2013 | 60 | 0.110 |
Why?
|
| Polymethyl Methacrylate | 1 | 2012 | 23 | 0.100 |
Why?
|
| Emergencies | 1 | 2014 | 174 | 0.100 |
Why?
|
| Amputation Stumps | 1 | 2012 | 2 | 0.100 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 71 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 657 | 0.100 |
Why?
|
| Mental Health | 1 | 2016 | 347 | 0.100 |
Why?
|
| Polytetrafluoroethylene | 1 | 2013 | 80 | 0.100 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2013 | 51 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2012 | 99 | 0.100 |
Why?
|
| Kidney | 3 | 2016 | 1335 | 0.100 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2012 | 76 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 132 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 1 | 2013 | 87 | 0.100 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2012 | 86 | 0.100 |
Why?
|
| Aortic Diseases | 1 | 2014 | 197 | 0.100 |
Why?
|
| Device Removal | 1 | 2013 | 222 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 115 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2013 | 206 | 0.100 |
Why?
|
| Balloon Occlusion | 1 | 2011 | 43 | 0.090 |
Why?
|
| Research Design | 3 | 2010 | 676 | 0.090 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 169 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 234 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 622 | 0.090 |
Why?
|
| Bile | 2 | 2008 | 46 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2014 | 782 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2015 | 555 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 424 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3369 | 0.090 |
Why?
|
| Database Management Systems | 1 | 2010 | 31 | 0.090 |
Why?
|
| Catheterization, Peripheral | 1 | 2012 | 126 | 0.090 |
Why?
|
| DNA, Viral | 3 | 2006 | 479 | 0.090 |
Why?
|
| Models, Statistical | 2 | 2019 | 470 | 0.090 |
Why?
|
| Contrast Media | 1 | 2014 | 470 | 0.090 |
Why?
|
| Anesthesia | 1 | 2012 | 211 | 0.080 |
Why?
|
| Viral Load | 3 | 2006 | 381 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 228 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 280 | 0.080 |
Why?
|
| Biomarkers | 4 | 2017 | 2943 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 2 | 2008 | 76 | 0.080 |
Why?
|
| Cold Ischemia | 1 | 2008 | 16 | 0.080 |
Why?
|
| Fatal Outcome | 2 | 2006 | 355 | 0.080 |
Why?
|
| P-Selectin | 1 | 2008 | 77 | 0.080 |
Why?
|
| Body Height | 2 | 2007 | 210 | 0.080 |
Why?
|
| Perfusion | 2 | 2008 | 198 | 0.080 |
Why?
|
| Laminectomy | 1 | 2008 | 26 | 0.080 |
Why?
|
| Surgical Stapling | 1 | 2008 | 17 | 0.080 |
Why?
|
| Phlebography | 1 | 2008 | 51 | 0.080 |
Why?
|
| Transplants | 1 | 2008 | 35 | 0.070 |
Why?
|
| Bile Canaliculi | 1 | 2007 | 4 | 0.070 |
Why?
|
| Young Adult | 2 | 2019 | 8855 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2008 | 108 | 0.070 |
Why?
|
| Bradycardia | 1 | 2007 | 59 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2014 | 581 | 0.070 |
Why?
|
| Depression | 1 | 2016 | 1227 | 0.070 |
Why?
|
| Thrombectomy | 1 | 2008 | 103 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 371 | 0.070 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2007 | 95 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2007 | 112 | 0.070 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2007 | 27 | 0.070 |
Why?
|
| Eligibility Determination | 1 | 2007 | 37 | 0.070 |
Why?
|
| Risk Adjustment | 1 | 2007 | 58 | 0.070 |
Why?
|
| Government Regulation | 1 | 2007 | 42 | 0.070 |
Why?
|
| Resource Allocation | 1 | 2007 | 52 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2007 | 208 | 0.070 |
Why?
|
| Plasma Cells | 1 | 2007 | 54 | 0.070 |
Why?
|
| Hemangioendothelioma | 1 | 2006 | 25 | 0.070 |
Why?
|
| CD3 Complex | 1 | 2006 | 84 | 0.070 |
Why?
|
| Social Justice | 1 | 2007 | 55 | 0.070 |
Why?
|
| Bile Duct Neoplasms | 1 | 2007 | 109 | 0.070 |
Why?
|
| Cholangiocarcinoma | 1 | 2007 | 107 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2007 | 209 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2008 | 193 | 0.070 |
Why?
|
| Thrombolytic Therapy | 1 | 2008 | 204 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2007 | 193 | 0.060 |
Why?
|
| Diabetic Retinopathy | 2 | 2006 | 155 | 0.060 |
Why?
|
| Hypotension | 1 | 2007 | 177 | 0.060 |
Why?
|
| Epoprostenol | 1 | 2006 | 67 | 0.060 |
Why?
|
| Cross Circulation | 1 | 2005 | 5 | 0.060 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 158 | 0.060 |
Why?
|
| Hemoperfusion | 1 | 2005 | 4 | 0.060 |
Why?
|
| Liver, Artificial | 1 | 2005 | 9 | 0.060 |
Why?
|
| Dialysis | 1 | 2005 | 20 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2012 | 973 | 0.060 |
Why?
|
| Anthropometry | 1 | 2006 | 197 | 0.060 |
Why?
|
| Life Support Care | 1 | 2006 | 45 | 0.060 |
Why?
|
| Plasmapheresis | 1 | 2005 | 29 | 0.060 |
Why?
|
| Hemodiafiltration | 1 | 2005 | 17 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2006 | 165 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2007 | 269 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 2006 | 89 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2007 | 268 | 0.060 |
Why?
|
| Hypertension, Portal | 1 | 2006 | 78 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2008 | 227 | 0.060 |
Why?
|
| Portal Pressure | 1 | 2005 | 5 | 0.060 |
Why?
|
| Body Weight | 2 | 2007 | 1000 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 321 | 0.060 |
Why?
|
| Hemochromatosis | 1 | 2005 | 32 | 0.060 |
Why?
|
| Extracorporeal Circulation | 1 | 2005 | 53 | 0.060 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2005 | 7 | 0.060 |
Why?
|
| Albumins | 1 | 2005 | 88 | 0.060 |
Why?
|
| Primates | 1 | 2005 | 81 | 0.060 |
Why?
|
| Gastroschisis | 1 | 2005 | 53 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2006 | 8106 | 0.060 |
Why?
|
| Ependyma | 1 | 2005 | 7 | 0.060 |
Why?
|
| Iron | 1 | 2007 | 262 | 0.060 |
Why?
|
| Choroid Plexus | 1 | 2005 | 23 | 0.060 |
Why?
|
| Kupffer Cells | 1 | 2005 | 19 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 253 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2005 | 57 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2006 | 196 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2006 | 402 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 94 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 88 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2007 | 356 | 0.060 |
Why?
|
| Hepatectomy | 1 | 2005 | 109 | 0.060 |
Why?
|
| Portal Vein | 1 | 2005 | 91 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2005 | 81 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2012 | 1548 | 0.060 |
Why?
|
| Arm | 1 | 2024 | 75 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 158 | 0.060 |
Why?
|
| Survivors | 1 | 2007 | 345 | 0.060 |
Why?
|
| Florida | 1 | 2004 | 73 | 0.060 |
Why?
|
| Nutritional Status | 1 | 2006 | 305 | 0.060 |
Why?
|
| Muromonab-CD3 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Sphingosine | 1 | 2004 | 12 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1009 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2004 | 62 | 0.060 |
Why?
|
| Propylene Glycols | 1 | 2004 | 18 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 217 | 0.060 |
Why?
|
| Creatinine | 1 | 2006 | 380 | 0.060 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2004 | 32 | 0.060 |
Why?
|
| Fatigue | 1 | 2005 | 216 | 0.060 |
Why?
|
| Hypoglycemia | 1 | 2005 | 191 | 0.060 |
Why?
|
| Consensus | 2 | 2017 | 607 | 0.050 |
Why?
|
| Malnutrition | 1 | 2006 | 197 | 0.050 |
Why?
|
| Administration, Topical | 2 | 2014 | 141 | 0.050 |
Why?
|
| Pancreas | 1 | 2004 | 211 | 0.050 |
Why?
|
| Animals | 6 | 2008 | 33792 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 398 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2004 | 146 | 0.050 |
Why?
|
| Insulin | 2 | 2008 | 1200 | 0.050 |
Why?
|
| Rituximab | 1 | 2004 | 155 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 1071 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2003 | 253 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 807 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2005 | 305 | 0.050 |
Why?
|
| ROC Curve | 2 | 2015 | 558 | 0.050 |
Why?
|
| Emotions | 1 | 2005 | 361 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 861 | 0.050 |
Why?
|
| Swine | 1 | 2005 | 1155 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2005 | 439 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 561 | 0.050 |
Why?
|
| Suture Techniques | 2 | 2013 | 196 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2006 | 434 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 1306 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 2012 | 240 | 0.050 |
Why?
|
| Linear Models | 2 | 2012 | 669 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 630 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2005 | 1119 | 0.040 |
Why?
|
| Metatarsus | 1 | 2020 | 2 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 66 | 0.040 |
Why?
|
| Cytokines | 1 | 2006 | 1284 | 0.040 |
Why?
|
| Knee | 1 | 2020 | 17 | 0.040 |
Why?
|
| Metals | 1 | 2020 | 61 | 0.040 |
Why?
|
| Drug-Eluting Stents | 1 | 2020 | 54 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2011 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2004 | 660 | 0.040 |
Why?
|
| Anxiety | 1 | 2005 | 961 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2019 | 173 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 1008 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 770 | 0.040 |
Why?
|
| Burnout, Professional | 1 | 2019 | 114 | 0.040 |
Why?
|
| Inflammation | 1 | 2005 | 1403 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 1593 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1522 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 75 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 715 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 88 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 1311 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1583 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 3076 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 1214 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 197 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2014 | 5 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2014 | 13 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2014 | 56 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 458 | 0.030 |
Why?
|
| Boston | 1 | 2014 | 110 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 291 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 35 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2014 | 46 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2017 | 483 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 252 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 354 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 449 | 0.030 |
Why?
|
| Jugular Veins | 1 | 2013 | 75 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2014 | 101 | 0.030 |
Why?
|
| Powders | 1 | 2013 | 25 | 0.030 |
Why?
|
| Tobramycin | 1 | 2012 | 23 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 2013 | 37 | 0.030 |
Why?
|
| Antisepsis | 1 | 2012 | 10 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 2013 | 30 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2013 | 43 | 0.030 |
Why?
|
| Anesthesia Recovery Period | 1 | 2012 | 23 | 0.030 |
Why?
|
| Disarticulation | 1 | 2012 | 2 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2013 | 103 | 0.030 |
Why?
|
| Gentamicins | 1 | 2012 | 95 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3234 | 0.030 |
Why?
|
| Heparin | 1 | 2014 | 227 | 0.030 |
Why?
|
| Hip Joint | 1 | 2012 | 38 | 0.030 |
Why?
|
| Catheters | 1 | 2012 | 89 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 241 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 925 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2008 | 1325 | 0.020 |
Why?
|
| Rats | 2 | 2008 | 3651 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 87 | 0.020 |
Why?
|
| Antiviral Agents | 2 | 2006 | 743 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 738 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 203 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1138 | 0.020 |
Why?
|
| Raffinose | 1 | 2008 | 6 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 2008 | 19 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2008 | 16 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2013 | 491 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2008 | 133 | 0.020 |
Why?
|
| Stroke | 1 | 2016 | 955 | 0.020 |
Why?
|
| Polyvinyl Alcohol | 1 | 2008 | 10 | 0.020 |
Why?
|
| Platinum | 1 | 2008 | 12 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 205 | 0.020 |
Why?
|
| Splenic Artery | 1 | 2008 | 22 | 0.020 |
Why?
|
| Aspartate Aminotransferase, Mitochondrial | 1 | 2007 | 1 | 0.020 |
Why?
|
| Ceruloplasmin | 1 | 2007 | 12 | 0.020 |
Why?
|
| Allopurinol | 1 | 2008 | 70 | 0.020 |
Why?
|
| Copper-transporting ATPases | 1 | 2007 | 25 | 0.020 |
Why?
|
| Adenosine | 1 | 2008 | 126 | 0.020 |
Why?
|
| Renal Artery | 1 | 2008 | 74 | 0.020 |
Why?
|
| Splenectomy | 1 | 2008 | 60 | 0.020 |
Why?
|
| Trace Elements | 1 | 2007 | 24 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2008 | 122 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2008 | 133 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 170 | 0.020 |
Why?
|
| Glutathione | 1 | 2008 | 193 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 966 | 0.020 |
Why?
|
| Biological Transport | 1 | 2007 | 347 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2007 | 36 | 0.020 |
Why?
|
| Neutrophils | 1 | 2008 | 373 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2008 | 457 | 0.020 |
Why?
|
| Living Donors | 1 | 2007 | 112 | 0.020 |
Why?
|
| Remission Induction | 1 | 2006 | 300 | 0.020 |
Why?
|
| Salivary Glands, Minor | 1 | 2005 | 10 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 287 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2008 | 306 | 0.020 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2007 | 113 | 0.020 |
Why?
|
| Actins | 1 | 2007 | 341 | 0.020 |
Why?
|
| Hypertension | 1 | 2014 | 1286 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 2006 | 110 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 537 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2005 | 169 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 324 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2005 | 195 | 0.010 |
Why?
|
| C-Peptide | 1 | 2005 | 112 | 0.010 |
Why?
|
| Endoscopy | 1 | 2007 | 282 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2005 | 145 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2006 | 236 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 231 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2006 | 348 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2006 | 756 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1290 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 1584 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 2809 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 4283 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 3545 | 0.010 |
Why?
|